Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1989;67(5):509–514.

Treatment of chronic experimental Trypanosoma cruzi infections in mice with MK-436, a 2-substituted 5-nitroimidazole.

S G Andrade, R C Silva, C M Santiago
PMCID: PMC2491297  PMID: 2515007

Abstract

The antiprotozoal drug 3-(1-methyl-5-nitroimidazol-2-yl)-3a, 4,5,6,7,7a-hexahydro-1,2-benzisoxazole (MK-436) is highly efficacious for treating mice chronically infected with different strains of Trypanosoma cruzi. The compound was administered by gavage in two daily doses of 250 mg per kg body weight to 130 mice that had been infected for 90 to 400 days with either type II or III strains of T. cruzi. The following parasitological cure tests were carried out: xenodiagnosis, haemoculture, and inoculation of blood into newborn mice. Indirect immunofluorescence tests and histopathological studies were also performed. The results indicate that the drug is highly efficacious against chronic infection caused by both type II (cure rate, 90%) and type III strains (cure rate, 95.7%). Histopathological examinations showed complete clearance of the cardiac and muscular lesions in 36% of the mice infected with type II strains and a decrease in the intensity and extension of the lesions in mice infected with type III strains. Indirect immunofluorescence tests were persistently positive for all the mice 3-6 months after the treatment.

Full text

PDF
510

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade S. G., Freitas L. A., Peyrol S., Pimentel A. R., Sadigursky M. Trypanosoma cruzi antigens detected by immunoelectron microscopy in the spleen of mice serologically positive but parasitologically cured by chemotherapy. (Preliminary report). Rev Soc Bras Med Trop. 1988 Jan-Mar;21(1):41–42. doi: 10.1590/s0037-86821988000100010. [DOI] [PubMed] [Google Scholar]
  2. Andrade S. G., Grimaud J. A. Chronic murine myocarditis due to Trypanosoma cruzi--an ultrastructural study and immunochemical characterization of cardiac interstitial matrix. Mem Inst Oswaldo Cruz. 1986 Jan-Mar;81(1):29–41. doi: 10.1590/s0074-02761986000100004. [DOI] [PubMed] [Google Scholar]
  3. Andrade S. G., Magalhães J. B., Pontes A. L. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull World Health Organ. 1985;63(4):721–726. [PMC free article] [PubMed] [Google Scholar]
  4. Andrade S. G., Silva R. C., Santiago C. M., Freitas L. A. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study. Bull World Health Organ. 1987;65(5):625–633. [PMC free article] [PubMed] [Google Scholar]
  5. Andrade Z. A., Andrade S. G., Sadigursky M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol. 1987 Jun;127(3):467–473. [PMC free article] [PubMed] [Google Scholar]
  6. Avila J. L., Avila A. Trypanosoma cruzi: allopurinol in the treatment of mice with experimental acute Chagas disease. Exp Parasitol. 1981 Apr;51(2):204–208. doi: 10.1016/0014-4894(81)90109-0. [DOI] [PubMed] [Google Scholar]
  7. Camargo M. E. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo. 1966 Sep-Oct;8(5):227–235. [PubMed] [Google Scholar]
  8. Filardi L. S., Brener Z. A nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections. Ann Trop Med Parasitol. 1982 Jun;76(3):293–297. doi: 10.1080/00034983.1982.11687544. [DOI] [PubMed] [Google Scholar]
  9. McCabe R. E., Remington J. S., Araujo F. G. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. J Infect Dis. 1984 Oct;150(4):594–601. doi: 10.1093/infdis/150.4.594. [DOI] [PubMed] [Google Scholar]
  10. Murray P. K., Habbersett M. C., Meurer R. D. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice. Am J Trop Med Hyg. 1983 Nov;32(6):1242–1250. doi: 10.4269/ajtmh.1983.32.1242. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES